Molecular Basis for Class V β-Tubulin Effects on Microtubule Assembly and Paclitaxel Resistance

被引:35
作者
Bhattacharya, Rajat [1 ]
Cabral, Fernando [1 ]
机构
[1] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
HAMSTER OVARY CELLS; CONFER RESISTANCE; C-TERMINUS; CAENORHABDITIS-ELEGANS; ANTIMITOTIC DRUGS; ALPHA-TUBULIN; ISOTYPES; EXPRESSION; MUTATIONS; MECHANISMS;
D O I
10.1074/jbc.M900167200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Vertebrates produce at least seven distinct beta-tubulin isotypes that coassemble into all cellular microtubules. The functional differences among these tubulin isoforms are largely unknown, but recent studies indicate that tubulin composition can affect microtubule properties and cellular microtubule-dependent behavior. One of the isotypes whose incorporation causes the largest change in microtubule assembly is beta 5-tubulin. Overexpression of this isotype can almost completely destroy the microtubule network, yet it appears to be required in smaller amounts for normal mitotic progression. Moderate levels of overexpression can also confer paclitaxel resistance. Experiments using chimeric constructs and site-directed mutagenesis now indicate that the hypervariable C-terminal region of beta 5 plays no role in these phenotypes. Instead, we demonstrate that two residues found in beta 5 (Ser-239 and Ser-365) are each sufficient to inhibit microtubule assembly and confer paclitaxel resistance when introduced into beta 1-tubulin; yet the single mutation of residue Ser-239 in beta 5 eliminates its ability to confer these phenotypes. Despite the high degree of conservation among beta-tubulin isotypes, mutations affecting residue 365 demonstrate that amino acid substitutions can be context sensitive; i.e. an amino acid change in one isotype will not necessarily produce the same phenotype when introduced into a different isotype. Modeling studies indicate that residue Cys-239 of beta 1-tubulin is close to a highly conserved Cys-354 residue suggesting the possibility that disulfide formation could play a significant role in the stability of microtubules formed with beta 1-but not with beta 5-tubulin.
引用
收藏
页码:13023 / 13032
页数:10
相关论文
共 55 条
[1]
MUTATIONS IN ALPHA-TUBULIN AND BETA-TUBULIN AFFECT SPINDLE FORMATION IN CHINESE-HAMSTER OVARY CELLS [J].
ABRAHAM, I ;
MARCUS, M ;
CABRAL, F ;
GOTTESMAN, MM .
JOURNAL OF CELL BIOLOGY, 1983, 97 (04) :1055-1061
[2]
NUCLEOTIDE-SEQUENCES OF 3 DIFFERENT ISOFORMS OF BETA-TUBULIN CDNA FROM CHINESE-HAMSTER OVARY CELLS [J].
AHMAD, S ;
SINGH, B ;
GUPTA, RS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1090 (02) :252-254
[3]
STABLE EXPRESSION OF HETEROLOGOUS MICROTUBULE-ASSOCIATED PROTEINS (MAPS) IN CHINESE-HAMSTER OVARY CELLS - EVIDENCE FOR DIFFERING ROLES OF MAPS IN MICROTUBULE ORGANIZATION [J].
BARLOW, S ;
GONZALEZGARAY, ML ;
WEST, RR ;
OLMSTED, JB ;
CABRAL, F .
JOURNAL OF CELL BIOLOGY, 1994, 126 (04) :1017-1029
[4]
A ubiquitous β-tubulin disrupts microtubule assembly and inhibits cell proliferation [J].
Bhattacharya, R ;
Cabral, F .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (07) :3123-3131
[5]
A minor β-tubulin essential for mammalian cell proliferation [J].
Bhattacharya, Rajat ;
Frankfurter, Anthony ;
Cabral, Fernando .
CELL MOTILITY AND THE CYTOSKELETON, 2008, 65 (09) :708-720
[6]
Blade K, 1999, J CELL SCI, V112, P2213
[7]
A CHICKEN-YEAST CHIMERIC BETA-TUBULIN PROTEIN IS INCORPORATED INTO MOUSE MICROTUBULES INVIVO [J].
BOND, JF ;
FRIDOVICHKEIL, JL ;
PILLUS, L ;
MULLIGAN, RC ;
SOLOMON, F .
CELL, 1986, 44 (03) :461-468
[8]
Thiol-disulphide interchange in tubulin: kinetics and the effect on polymerization [J].
Britto, PJ ;
Knipling, L ;
McPhie, P ;
Wolff, J .
BIOCHEMICAL JOURNAL, 2005, 389 :549-558
[9]
The role of β-tubulin isotypes in resistance to antimitotic drugs [J].
Burkhart, CA ;
Kavallaris, M ;
Horwitz, SB .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1471 (02) :O1-O9
[10]
RESISTANCE TO ANTIMITOTIC AGENTS AS GENETIC PROBES OF MICROTUBULE STRUCTURE AND FUNCTION [J].
CABRAL, F ;
BARLOW, SB .
PHARMACOLOGY & THERAPEUTICS, 1991, 52 (02) :159-171